Effects of 5-aminolaevulinic acid on human ovarian cancer cells and human vascular endothelial cells in vitro

Keyphrases

• 5-Aminolevulinic Acid (5-ALA) 100%
• Human Ovarian Cancer Cell 100%
• Human Vascular Endothelial Cells 100%
• Photodynamic Therapy 80%
• Tumor Epithelial Cells 60%
• Acid Activation 60%
• Protoporphyrin IX (PpIX) 60%
• Endothelial Cells 40%
• Human Umbilical Vein 40%
• Cellular Alterations 40%
• Electron Microscopy 20%
• Mitochondrial Function 20%
• Cytotoxicity 20%
• Therapy Efficacy 20%
• Cell-derived 20%
• High Sensitivity 20%
• Therapy Effect 20%
• Gel Electrophoresis 20%
• Cellular Effects 20%
• Trypan Blue Assay 20%
• Clinical Value 20%
• Thiazolyl 20%
• Cell Membrane Permeability 20%
• Cystadenocarcinoma 20%
• MTT Assay 20%
• Chemotherapeutic Regimens 20%
• Minimal Residual Disease 20%
• Phototherapeutic 20%
• Serous Ovarian Carcinoma 20%
• 5-aminolevulinic Acid Photodynamic Therapy 20%
• Dark Toxicity 20%

Medicine and Dentistry

• In Vitro 100%
• Cancer Cell 100%
• Vascular Endothelial Cell 100%
• Ovarian Cancer 100%
• Aminolevulinic Acid 100%
• Photochemotherapy 83%
• Neoplasm 50%
• Epithelial Cell 50%
• Protoporphyrin 50%
• Endothelial Cell 33%
• Umbilical Vein 33%
• Electron Microscopy 16%
• Cytotoxicity 16%
• Krukenberg Tumor 16%
• Gel Electrophoresis 16%
• Therapy Effect 16%
• Trypan Blue 16%
• Minimal Residual Disease 16%
• Mucinous Cystadenocarcinoma 16%
• Cell Membrane Permeability 16%
• MTT Assay 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Ovary Cancer 100%
• Aminolevulinic Acid 100%
• Photodynamic Therapy 83%
• Epithelium Tumor 50%
• Protoporphyrin IX 50%
• Electron Microscopy 16%
• Ovary Carcinoma 16%
• Trypan Blue 16%
• Minimal Residual Disease 16%
• Cystadenocarcinoma 16%
• Cytotoxicity 16%
• Gel Electrophoresis 16%